No Picture
San Diego Biotech Jobs

Director, GI / Inflammation Drug Discovery Research – Takeda Pharmaceuticals – San Diego, CA

As a Director, GI / Inflammation Drug Discovery Research working on the Gastroenterology Drug Discovery Unit team, you will be empowered to create and…From Takeda Pharmaceuticals – Tue, 20 Apr 2021 13:54:22 GMT – View all San Diego, CA jobs […]

No Picture
San Diego Biotech Jobs

Physician Scientist Translational Research Leader Inflammation/IBD Medical Director Translational Research – Takeda Pharmaceuticals – San Diego, CA

The Physician Scientist Translational Research Leader Inflammation/IBD Medical Director Translational Research is a global leader responsible to provide medical…From Takeda Pharmaceuticals – Tue, 20 Apr 2021 13:54:13 GMT – View all San Diego, CA jobs […]

No Picture
San Diego Biotech Jobs

Sr. Manager Alliance and Project Management – Takeda Pharmaceuticals – San Diego, CA

Sound scientific knowledge with Bachelor’s degree (or higher) in Science or Management related discipline with 5-9 years of experience in the biotechnology or…From Takeda Pharmaceuticals – Tue, 20 Apr 2021 13:54:12 GMT – View all San Diego, CA jobs […]

No Picture
News

Novel Sleep Biomarkers Linked to Neurodegenerative Disease

CARLSBAD, Calif.–(BUSINESS WIRE)–Advanced Brain Monitoring, Inc. announces the discovery of two novel sleep biomarkers linked to neurodegenerative disease at the annual meeting of the American Academy of Neurology (AAN). “The biomarkers were discovered with the company’s Sleep Profiler™, while being used by National Institute of Health-funded research collaborators across seven… Click here to view original post… […]

No Picture
News

Janux Therapeutics Closes $125 Million Series B Financing to Advance Next Generation T Cell Engager Immunotherapies into Clinical Trials

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics Closes $125 Million Series B Financing to Advance Next Generation T Cell Engager Immunotherapies into Clinical Trials Click here to view original post… […]

No Picture
News

Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that Luisa Salter-Cid, Ph.D., Gossamer’s Chief Scientific Officer, is resigning from Gossamer effective April 30, 2021. On that date,… Click here to view original post… […]